Project CBD Newsletter: CBD for Neuroinflammation Alzheimers Neuropathic Pain Oral Health Acne Medical Cannabis Sick Leave and DEA Rescheduling Update
Project CBD Newsletter: CBD for Neuroinflammation, Alzheimerβs, Neuropathic Pain, Oral Health, Acne, Medical Cannabis Sick Leave, and DEA Rescheduling Update https://ift.tt/jRcF6On This weekβs plant medicine newsletter covers CBDβs potential for neuroinflammation and Alzheimerβs disease, new research on CBD for chemotherapy-induced pain, oral health, and acne, plus updates on medical cannabis in the workplace and the DEAβs rescheduling proceedings. Noteworthy Read Can CBD Play a Role in Treating Alzheimerβs Disease? (Dr. Andrew Weil) Dr. Andrew Weil reviews emerging evidence that CBD may have relevance for Alzheimerβs disease, particularly through its effects on neuroinflammation and brain immune activity. The piece looks at CBD within the broader conversation about how cannabinoids may help protect the aging brain and support new approaches to neurodegenerative disease. Read the full article Note: Project CBD interviewed Dr. Weil in 2023 on cannabis and integrative medicine. Read the interview here. View more in CBD More Noteworthy Reading Medical Cannabis Cuts Employee Sick Days (Inc.) Inc. reports on research linking medical cannabis access to fewer health-related work absences, with employee sick days falling by about 7% in states with medical cannabis laws. The findings suggest legal access may help some workers better manage chronic symptoms and remain active in the workforce. Read more View more in CBD US Tobacco Giant Is Behind Planned Takeover of Biggest Licensed Dutch Cannabis Grower (Cannabis Law Report) Cannabis Law Report highlights a planned takeover involving the Netherlandsβ largest licensed cannabis grower and a major U.S. tobacco company. The story underscores the growing interest of legacy tobacco firms in regulated cannabis markets as medical and adult-use systems mature. Read more View more in CBD DEA Argues in Favor of Moving Cannabis to Schedule III (Ganjapreneur) The DEA has spent years dragging its feet on cannabis rescheduling, and now itβs standing in its own courtroom, calling its own witnesses, and arguing that the rule should actually go into effect. Read more View more in THC Research Round-Up CBD Attenuates Chemo-Induced Peripheral Neuropathic Pain (PubMed) New research suggests CBD may reduce chemotherapy-induced peripheral neuropathic pain, a common and difficult side effect of cancer treatment. The study connects CBDβs pain-modulating effects with endocannabinoid and lipid signaling pathways, adding to interest in cannabinoids as supportive tools in oncology care. Read more View more in Endocannabinoid System CBD Mouthwash Effective Without Damaging Enamel (Marijuana Herald) A new study found that a low-concentration CBD mouthwash helped control dental biofilm without damaging enamel properties. The findings point to CBDβs potential in oral health formulations, especially as researchers explore alternatives to conventional antimicrobial ingredients. Read more View more in CBD CBD-Rich Cannabis Extracts and CBD Isolate for Acne (Molecules) A new review examines CBD-rich cannabis extracts and isolated CBD as potential tools for managing inflammatory acne. The authors highlight CBDβs anti-inflammatory and sebum-regulating properties, connecting cannabinoid science with a growing interest in plant-derived dermatology. Read more View more in CBD A heartfelt thank you to all of the CBD brands whose generous support allows Project CBD to shine a light on the latest plant medicine research and bring these stories to our readers each week. The post Project CBD Newsletter: CBD for Neuroinflammation, Alzheimerβs, Neuropathic Pain, Oral Health, Acne, Medical Cannabis Sick Leave, and DEA Rescheduling Update appeared first on Project CBD. via Project CBD https://projectcbd.org July 3, 2026 at 12:36PM















